For more information on author guidelines, an explanation of our peer review process, and conflict of interest informed consent policies, please go to http://www.wiley.com/bw/submit.asp?ref=1094-7159&site=1
Incidence and Avoidance of Neurologic Complications with Paddle Type Spinal Cord Stimulation Leads
Version of Record online: 3 OCT 2011
© 2011 International Neuromodulation Society
Neuromodulation: Technology at the Neural Interface
Volume 14, Issue 5, pages 412–422, September/October 2011
How to Cite
Levy, R., Henderson, J., Slavin, K., Simpson, B. A., Barolat, G., Shipley, J. and North, R. (2011), Incidence and Avoidance of Neurologic Complications with Paddle Type Spinal Cord Stimulation Leads. Neuromodulation: Technology at the Neural Interface, 14: 412–422. doi: 10.1111/j.1525-1403.2011.00395.x
Conflict of Interest: Dr. Levy consults for Medtronic, Spinal Modulation, Vertos, Boston Scientific, St. Jude Medical, Bioness, NuCurrent, and Codman & Shurtleff. Dr. Henderson has served as a consultant (paid) for NDI Medical, Johnson & Johnson (paid), and Proteus Biomedical (stock options). He serves on the Scientific Advisory Board of Nevro Corporation (stock options). He previously served on the Scientific Advisory Board of Intelect Medical (stock options, royalties), which was recently sold to Boston Scientific. He has received teaching honoraria from Medtronic, Inc. He has received research funding from the Michael J. Fox Foundation, the Davis Phinney Foundation, the John A. Blume Foundation, the Wallace Coulter Foundation, the Beckman Foundation, the Bob and Ruth Halperin Foundation, the Stanford Institute for Neuro-Innovation and Translational Neuroscience, and the National Institutes of Health. He is in negotiation with Boston Scientific for a consulting contract. Dr. Slavin is a paid consultant and has received honoraria, consulting fees, and/or research support from the following companies: St. Jude Medical; Medtronic; Boston Scientific; Bioness; Greatbatch. Mr. Simpson gave a talk last year, which was sponsored by St. Jude Medical, but the fee was paid to his department. Dr. Barolat is a consultant for Medtronic and St. Jude Medical and a Consultant/equity owner of QIG group. Ms. Shipley's employer (The Neuromodulation Foundation) has consulting agreements with and unrestricted educational grants from the companies that manufacture SCS equipment. Dr. North's current (Sinai Hospital of Baltimore) and former employers (Johns Hopkins University) received funding from industry (Boston Scientific, Inc.; Medtronic, Inc.; St. Jude Medical, Inc.) as does the non-profit Neuromodulation Foundation, of which he is an unpaid officer. He has consulting/equity interest in Algostim LLC.
- Issue online: 3 OCT 2011
- Version of Record online: 3 OCT 2011
- Received: June 10, 2011 Revised: June 29, 2011 Accepted: June 30, 2011
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!